A drug designed to tackle diabetes could also be repurposed
Read moreHome »
(HealthDay)—Real-world evidence shows that rivaroxaban reduces the risk for recurrent
Read moreA UCLA-led study suggests that for people with recurrent glioblastoma,
Read morePatients with venous thromboembolism (VTE) carry a high risk of
Read moreAn immune response to pregnancy (in which the uterus rejects
Read moreNew research indicates that for women with advanced epithelial ovarian
Read more